Concepedia

Wajeeha Ansari

WA

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2024

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Wajeeha Ansari is an author at Pfizer (United States) specializing in infectious diseases, burden of illness analysis, and burden of illness assessment.

ORCID

Publications per year

2024–2024

4

Publications

4

Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19

Amie Scott, Wajeeha Ansari, Farid Khan et al. · BMC Medicine · 2024 · 24 citations · Full text

, , +17

Substantial health and economic burden of COVID-19 during the year after acute illness among US adults not at high risk of severe COVID-19

Amie Scott, Wajeeha Ansari, Richard Chambers et al. · BMC Medicine · 2024 · 18 citations · Full text

, , +15

Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial

Jennifer Hammond, Heidi Leister‐Tebbe, Annie Gardner et al. · Clinical Infectious Diseases · 2024 · 15 citations · Full text

, , +14

Health-related quality of life in mild-to-moderate COVID-19 in the UK: a cross-sectional study from pre- to post-infection

Ioana-Alexandra Soare, Wajeeha Ansari, Jennifer L. Nguyen et al. · Health and Quality of Life Outcomes · 2024 · 13 citations · Full text

, , +17

1–4 of 4